Literature DB >> 18989652

[Venous interventions--part 1: techniques and lower torso thromboses].

L Kamper1, K Krüger, A Altenburg, M Mansour, P Reimer, P Haage.   

Abstract

Venous thrombosis is one of the most common vascular diseases. Without treatment, pulmonary embolism is a potentially life-threatening complication. Long-term complications are chronic venous insufficiency and post-thrombotic syndrome. Medical anticoagulation is currently the standard therapy, since it prevents appositional thrombus growth although it usually can not prevent the development of post-thrombotic syndrome. The structure of the thrombotic material often leads to partial recanalisation with residual stenosis. Early and sufficient systemic thrombolysis with adequate concentration may achieve disintegration of the thrombus and preservation of venous valve function. Supplementary to conservative therapy, local catheter thrombolysis is possible even in cases with contraindications for a systemic thrombolysis therapy. Additional interventional techniques reduce the required concentration of the thrombolytic. Venous stenosis can be treated by balloon angioplasty and stent implantation. This article reviews the different percutaneous treatment options as well as their application and usefulness in thrombosis of the lower torso.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18989652     DOI: 10.1007/s00117-008-1737-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  19 in total

1.  The potential role of thrombolytic therapy in venous thrombosis.

Authors:  A Markel; R A Manzo; D E Strandness
Journal:  Arch Intern Med       Date:  1992-06

Review 2.  Current status of percutaneous mechanical thrombectomy. Part II. Devices and mechanisms of action.

Authors:  M J Sharafuddin; M E Hicks
Journal:  J Vasc Interv Radiol       Date:  1998 Jan-Feb       Impact factor: 3.464

3.  Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.

Authors: 
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

4.  The effects of a mechanical thrombolytic device on normal canine vein valves.

Authors:  G McLennan; S O Trerotola; D Davidson; C A Rhodes; C Lazzaro; J Dreesen; G Tennery; K A Lane
Journal:  J Vasc Interv Radiol       Date:  2001-01       Impact factor: 3.464

5.  Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.

Authors:  M W Mewissen; G R Seabrook; M H Meissner; J Cynamon; N Labropoulos; S H Haughton
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

6.  Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Authors:  Vincenza Snow; Amir Qaseem; Patricia Barry; E Rodney Hornbake; Jonathan E Rodnick; Timothy Tobolic; Belinda Ireland; Jodi B Segal; Eric B Bass; Kevin B Weiss; Lee Green; Douglas K Owens
Journal:  Ann Intern Med       Date:  2007-01-29       Impact factor: 25.391

7.  Computed tomography findings in 10 cases of iliac vein compression (May-Thurner) syndrome.

Authors:  Levent Oguzkurt; Fahri Tercan; M Ali Pourbagher; Osman Kizilkilic; Riza Turkoz; Fatih Boyvat
Journal:  Eur J Radiol       Date:  2004-12-10       Impact factor: 3.528

Review 8.  [Iliofemoral and iliocaval interventions in deep venous thrombosis].

Authors:  P Haage; R W Günther
Journal:  Rofo       Date:  2005-05

9.  Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase.

Authors:  S Schulman; S Granqvist; A Juhlin-Dannfelt; D Lockner
Journal:  Acta Med Scand       Date:  1986

10.  Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis.

Authors:  Suresh Vedantham; Thomas M Vesely; Gregorio A Sicard; Daniel Brown; Brian Rubin; Luis A Sanchez; Naveen Parti; Daniel Picus
Journal:  J Vasc Interv Radiol       Date:  2004-06       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.